文献速递乳腺癌放疗

吸烟加重早期乳腺癌大分割IMRT后的慢性毒性

Smoking increases breast toxicity despite adjuvant hypofractionated IMRT in early breast cancer.
PubMed 文献 · Radiat Oncol · 2025-03-27

回顾性分析638例保乳术后接受大分割IMRT及近距离放疗加量的早期乳腺癌患者,566例有吸烟记录,中位随访6年。吸烟者与非吸烟者急性放射性皮炎发生率相似,但吸烟者慢性纤维化(35.6% vs 24.7%,p=0.013)和慢性疼痛(7.9% vs 3.3%,p=0.024)发生率显著更高,水肿无显著差异。

要点

  • 吸烟者慢性纤维化发生率35.6%,非吸烟者24.7%(p=0.013)。
  • 吸烟者慢性疼痛发生率7.9%,非吸烟者3.3%(p=0.024)。
  • 吸烟者与非吸烟者急性放射性皮炎发生率相似。

核心结论

  • 大分割IMRT改善总体毒性谱,但吸烟显著加重乳腺癌患者慢性毒性。
  • 研究强调将综合戒烟计划纳入癌症照护的迫切需求。

研究设计与样本

  • 回顾性研究,纳入2009至2017年接受保乳术后大分割IMRT及近距离放疗加量的早期乳腺癌患者638例,其中566例有吸烟记录。
  • 急性毒性在治疗结束时评估,慢性毒性在治疗后至少一年评估,采用CTCAE v4.0标准。
  • 统计分析包括卡方检验和相对危险度(RR)计算。

主要发现

  • 566例纳入分析,吸烟者占31.3%,中位随访6年(范围1-11年)。
  • 急性毒性以放射性皮炎为主:87.6%发生1级,5.5%发生2级,无≥3级病例,6.9%未发生放射性皮炎。
  • 出血罕见(1.1%),感染发生率为2.0%。
  • 慢性毒性:67.1%无纤维化,27.4%为1级纤维化,4.9%为2级,0.6%为3级,无4级纤维化;水肿8.0%,慢性疼痛4.4%。
  • 吸烟者慢性纤维化发生率35.6%,非吸烟者24.7%(p=0.013);吸烟者慢性疼痛发生率7.9%,非吸烟者3.3%(p=0.024);水肿吸烟者7.9% vs 非吸烟者8.0%(p=0.879),无显著差异。

临床怎么用

  • 原文结论强调将综合戒烟计划纳入癌症照护的迫切需求。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the impact of smoking on acute and chronic toxicity in early breast cancer patients treated with hypofractionated intensity-modulated radiation therapy (IMRT) and a brachytherapy boost following breast-conserving surgery. METHODS: A retrospective study of 638 patients treated between 2009 and 2017, with 566 having recorded smoking status. Acute toxicity was assessed at treatment end and chronic toxicity at least one-year post-treatment, using Common Terminology Criteria for Adverse Events v4.0. Statistical analyses included chi-square tests and relative risk (RR) calculations. RESULTS: A total of 566 patients were included in the study, with 31.3% being smokers. The cohort was followed for a median of 6 years (range: 1-11 years). Acute toxicity was primarily characterized by radiodermatitis, with 87.6% of patients developing grade 1 and 5.5% experiencing grade 2. No cases of grade ≥ 3 were observed, and 6.9% of patients did not experience radiodermatitis. Bleeding was rare (1.1%) and infections occurred in 2.0% of patients. Regarding chronic toxicity, 67.1% of patients had no fibrosis, while 27.4% had grade 1 fibrosis. Grade 2 and grade 3 fibrosis were observed in 4.9% and 0.6% of patients, respectively, with no cases of grade 4 fibrosis. Edema was present in 8.0%, and 4.4% of patients reported chronic pain. When comparing smokers and nonsmokers, acute toxicity incidence, particularly radiodermatitis, was similar between the two groups. Smokers had a significantly higher incidence of chronic fibrosis (35.6% vs. 24.7%, p = 0.013) and chronic pain (7.9% vs. 3.3%, p = 0.024) compared to nonsmokers. However, there were no significant differences in the occurrence of edema between smokers and nonsmokers (7.9% vs. 8.0%, p = 0.879). CONCLUSION: While advanced radiation techniques such as hypofractionated IMRT improve overall toxicity profiles, smoking significantly exacerbates chronic toxicity in breast cancer patients. This study underscores the urgent need for comprehensive smoking cessation programs as part of cancer care, addressing lifestyle factors to improve patient outcomes and quality of life.

来源:Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Díaz-Gavela AA, Del Cerro E, Sanchez-Garcia S, et al. Smoking increases breast toxicity despite adjuvant hypofractionated IMRT in early breast cancer. Radiat Oncol. 2025. PMID: 40148972. doi:10.1186/s13014-025-02614-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。